George Scorsis

Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'
Cannabis Co. Entourage Health Reports 126% YoY Increase In 2023 Gross Profit, Cuts Losses Significantly
Canadian Cannabis Co. Entourage Health Q3 Revenue Slides 8.8% YoY - But Margins Sore, Losses Decline
Cannabis Co. Entourage Health Reports 126% YoY Increase In 2023 Gross Profit, Cuts Losses Significantly
Canadian Cannabis Co. Entourage Health Q3 Revenue Slides 8.8% YoY - But Margins Sore, Losses Decline
Entourage Extends Supply Deal With Tilray's HEXO To Ensure Top-Quality Cannabis Products
Two Key Cannabis Trends Surged - Entourage Health's Financial Results Show Why

George Scorsis Recent News

Former Crime Analyst To Lead Michigan Cannabis Agency & Latest Key Executive Changes In Marijuana Space
Former Crime Analyst To Lead Michigan Cannabis Agency
Entourage Health Appoints James Afara As COO
Entourage Health Corp. (OTCQX: ETRGF) (TSX-V:ENTG) (FSE:4WE), a Canadian producer and distributor of cannabis products appointed James Afara as the company’s COO.
Entourage Health's Starseed Adds Four New Union Groups To Its Medical Cannabis Program
Starseed Medicinal a subsidiary of Entourage Health Corp.
Entourage Health Amends Its Credit Facilities To Improve Debt Position
Entourage Health Corp.
Entourage Health Debenture Holders Approve Proposed Amendments To 8.5% Unsecured Convertible Debentures
Entourage Health Corp.
Entourage Health Q1 Revenue Improves 17% Sequentially, What About Adjusted EBITDA?
Entourage Health Corp. (OTCQX: ETRGF) (TSX-V:ENTG)(FSE:4WE) released its financial results for the three months ended March 31, 2022, revealing total revenue of $15.8 million, up 17% sequentially over Q4 2021.
Pineapple Express Will Offer Same-Day Medical Cannabis Delivery To Entourage Health Patients
Pineapple Express Delivery Inc., a wholly-owned subsidiary of Fire & Flower Holdings Corp. (OTCQX: FFLWF) (TSX:FAF), has entered into an agreement with Entourage Health Corp.
Entourage Health Cannabis Co. Taps Vaani Maharaj To Serve As CFO
Canadian cannabis company Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has appointed Vaani Maharaj, a seasoned financial executive with broad experience in corporate finance, healthcare and consumer-packaged goods (CPG).
Entourage Health Upsizes Credit Facility With LiUNA Pension Fund For Extra $20M
Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) revealed Friday it has upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada for an extra $20 million in non-dilutive funding.
Entourage Health Posts $14.9 Million Record Revenue In Q3 Following Rebrand From WeedMD
Canadian producer and distributor of cannabis Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) announced its financial results Tuesday for the three and nine months ended Sept. 30, 2021.
Entourage Health Stock Slightly Up After Revealing Third Consecutive Quarter Of QoQ Revenue Growth And Expansion Of Saturday Cannabis Brand Into Quebec
Canadian cannabis producer Entourage Health Corp. (TSX-V: ENTG) (OTCQX: WDDMF) (FSE: 4WE), formerly known as WeedMD Inc., announced its
Cannabis Producer Entourage Health: Preliminary Record Q2 Revenue Of $13.6M After Name Change From WeedMD
Cannabis producer Entourage Health Corp. (TSXV: ENTG) (OTCQX: WDDMF) (FSE: 4WE), which recently rebranded from WeedMD Inc., reported that its preliminary unaudited revenues amounted to $13.6 million in the second quarter.
WeedMD To Rebrand And Become Entourage Health Corp As Part Of Its 'Evolution'
Cannabis producer WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) will change its corporate name to Entourage Health Corp. in the coming months.
WeedMD: 102% Record Increase In Q1 2021 Revenue, Adjusted EBITDA Improves Over $31M Sequentially
Medical cannabis company WeedMD Inc. (TSX-V: WMD) (OTCQX: WDDMF) (FSE: 4WE) saw gross revenue climb to CA$12.9 million ($10.46 million) in the first quarter of 2021 - a 7% spike compared to what the Toronto, Canada-based company
WeedMD Wraps Up Fiscal 2020 With $29.4M In Revenue, Reports Q1 2021 Preliminary Gross Revenue Of $12M
Medical cannabis company WeedMD Inc. (TSXV: WMD) (OTCQX: WDDMF) (FSE:4WE) reported Monday its revenue rose by 41% year-over-year, reaching CA$29.4 million ($24.3 million) in 2020.